24/7 Support Number +91-9137-44-1392

Dr Shruti Kate

Dr Shruti Kate

Dr. Shruti Kate serves as a Consultant at HCG Manavata Cancer Centre in Nashik, boasting 13 years of comprehensive experience in this field. Proficient in treating solid tumors, pediatric tumors, and hematological malignancies, she offers expertise across diverse oncological domains. Dr. Kate’s special interest lies in immunotherapy and metronomic therapy, offering advanced treatment options for patients with advanced cancers. With a remarkable track record, having handled over 50,000 cases, she stands as a pioneer of hope and healing in the fight against cancer.

Specialization

Dr. Shruti Kate is a medical specialist in the following major interventions including –

  • Gynecological Cancer
  • Genitourinary Cancer
  • Thoracic Cancer
  • Gastrointestinal Cancer
  • Hematologic Cancer
  • Breast Cancer

Education

  • Lady Hardinge Medical College, New Delhi (MBBS)
  • Maulana Azad Medical College, New Delhi (MD Internal Medicine )
  • Tata Memorial Hospital (DM Medical Oncology)

Career

  • Consultant – HCG Manavata Cancer Centre, Nashik

Memberships

Dr. Shruti Kate is a member of several reputed national & international oncological societies such as  –

  • ASCO (American Society of Clinical Oncology)
  • ESMO (European Society for Medical Oncology)
  • IASLC (International Association for the Study of Lung Cancer)
  • ISMPO (Indian Society of Medical and Pediatric Oncology)
  • IOS (Indiana Oncology Society)

Publications

Dr. Shruti Kate has authored many research works among them few are –

  • Outcome of uncommon EGFR mutation positive newly diagnosed advanced non-small cell lung cancer patients: a single center retrospective analysis. Lung Cancer (Auckl). 2019 Jan 29;10:1-10. 
  • Safety and efficacy of scalp cooling system in preventing chemotherapy induced alopecia – A single center prospective study. Cancer Treat Res Commun. 2021;26:100280.            
  • Evaluation of Prognostic Factors that Affect Survival Outcomes of Breast Cancer Patients with Brain Metastases: A Single Institutional Experience. Eur J Breast Health. 2020 Dec 24;17(1):62-67.            
  • A Retrospective Analysis of Invasive Fungal Diseases (IFD) of the Central Nervous System in Children With Lymphoid Malignancies. J Pediatr Hematol Oncol. 2020 May;42(4):e202-e206.
  • Thromboembolic events in patients with advanced stage non-small cell lung cancer treated with platinum-based chemotherapy: a prospective observational study. Ecancermedicalscience. 2018 Oct 9;12:876.  

Dr. Shruti Kate’s dedication to ongoing research and clinical trials underscores her commitment to advancing cancer treatment and care, ensuring patients have access to the latest innovations. With expertise in chemotherapy, immunotherapy, and targeted therapy, she tailors treatments to meet individual patient needs, offering the most effective options available. Dr. Kate’s proactive approach includes advocating for early detection and prevention through regular screenings and lifestyle modifications, empowering patients to reduce their cancer risk and improve outcomes.

© 2024 Uhapo Health Services (P) Ltd.